Exploring 2-[(5-Bromo-2-Methylphenyl)methyl]-5-(4-Fluorophenyl)thiophene: A Key Intermediate for Canagliflozin
Unlocking the potential of this vital compound in pharmaceutical development.
Get a Quote & SampleProduct Core Value
2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
This compound is a critical building block in the synthesis of Canagliflozin, a medication vital for managing type 2 diabetes. Its precise chemical structure and high purity ensure the quality and efficacy of the final pharmaceutical product.
- Discover the critical role of this 2-5-bromo-2-methylphenylmethyl-5-4-fluorophenylthiophene CAS 1030825-20-7 in pharmaceutical synthesis, ensuring reliable outcomes.
- Leverage high purity chemical compounds to guarantee the integrity of your drug development processes.
- Partner with trusted pharmaceutical intermediate suppliers in China for consistent quality and supply.
- Understand the importance of this specific type 2 diabetes medication precursor in the development of life-changing treatments.
Key Advantages Offered
Uncompromising Purity
Achieve superior results with intermediates boasting purity levels exceeding 99.0%, essential for demanding pharmaceutical applications.
Strategic Synthesis Intermediate
This compound's structure makes it an ideal precursor, facilitating complex organic synthesis pathways for potent APIs.
Reliable Global Sourcing
Benefit from established supply chains and manufacturers in China, ensuring consistent availability of this key pharmaceutical intermediate.
Key Applications
Pharmaceutical Intermediates
Serves as a fundamental building block for complex API synthesis, ensuring the efficient production of therapeutic agents.
Canagliflozin Synthesis
An indispensable component in the manufacturing process of Canagliflozin, a critical SGLT2 inhibitor for type 2 diabetes.
Advanced Organic Synthesis
Its versatile chemical structure allows for various transformations, making it valuable in custom synthesis projects for novel compounds.
Diabetes Drug Development
Plays a pivotal role in the creation of advanced treatments for metabolic disorders, particularly type 2 diabetes.